Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (11-20 of 297) with videos related to

Pageof 30
Sort By:
Current Rheumatology Reports|April 29, 2010
Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis?Alicia Peterson, John Varga
Current Rheumatology Reports|April 18, 2007
Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statinsMonique Hinchcliff, John Varga
Current Rheumatology Reports|November 26, 2010
B-cell-targeted therapy for the fibrotic complications of systemic sclerosisRobert Woodrick, John Varga
Expert Review of Clinical Immunology|May 19, 2010
Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapyMonique Hinchcliff, John Varga
Expert Opinion on Pharmacotherapy|July 25, 2006
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcersManu Jain, John Varga
The Journal of Clinical Investigation|March 3, 2007
Systemic sclerosis: a prototypic multisystem fibrotic disorderJohn Varga, David Abraham
Seminars in Cell & Developmental Biology|December 21, 2019
Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategiesYoshihide Asano, John Varga
Nature Reviews. Rheumatology|July 20, 2021
Linking autoimmunity, short telomeres and lung fibrosis in SScKatja Lakota, John Varga
Immunology Letters|October 2, 2017
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapySwati Bhattacharyya, John Varga
American Family Physician|October 29, 2008
Systemic sclerosis/scleroderma: a treatable multisystem diseaseMonique Hinchcliff, John Varga
Pageof 30

Showing results (11-20 of 297) with videos related to

Sort By:
Pageof 30
Current Rheumatology Reports|April 29, 2010
Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis?Alicia Peterson, John Varga
Current Rheumatology Reports|April 18, 2007
Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statinsMonique Hinchcliff, John Varga
Current Rheumatology Reports|November 26, 2010
B-cell-targeted therapy for the fibrotic complications of systemic sclerosisRobert Woodrick, John Varga
Expert Review of Clinical Immunology|May 19, 2010
Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapyMonique Hinchcliff, John Varga
Expert Opinion on Pharmacotherapy|July 25, 2006
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcersManu Jain, John Varga
The Journal of Clinical Investigation|March 3, 2007
Systemic sclerosis: a prototypic multisystem fibrotic disorderJohn Varga, David Abraham
Seminars in Cell & Developmental Biology|December 21, 2019
Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategiesYoshihide Asano, John Varga
Nature Reviews. Rheumatology|July 20, 2021
Linking autoimmunity, short telomeres and lung fibrosis in SScKatja Lakota, John Varga
Immunology Letters|October 2, 2017
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapySwati Bhattacharyya, John Varga
American Family Physician|October 29, 2008
Systemic sclerosis/scleroderma: a treatable multisystem diseaseMonique Hinchcliff, John Varga
Pageof 30